VEDL yields 42.08% · JNJ yields 2.13%● Live data
📍 VEDL pulled ahead of the other in Year 1
Combined, VEDL + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VEDL + JNJ for your $10,000?
Vedanta Limited operates as a diversified natural resources company in India. The company explores for, develops, produces, processes, and sells oil and gas, zinc, lead, silver, copper, aluminum, iron ore, steel, and power. It is involved in the exploration, development, and production of oil and gas; and exploration, mining, and processing of iron ore, pig iron, and metallurgical coke. The company also operates a thermal coal- based commercial power facility of 600 megawatts (MW) at Jharsuguda in the State of Odisha in eastern India; a 300 MW thermal coal based power plant at Korba; 1,980 MW (three units of 660 MW each) thermal coal- based commercial power facilities; 274MW of wind power plants; and a power plant situated at Mettur Dam in the state of Tamil Nadu in southern India. In addition, it manufactures and supplies billets, TMT bars, wire rods, and ductile iron pipes; engages in the mechanization of coal handling facilities and upgradation of general cargo berth for handling coal at the outer harbour of Visakhapatnam Port on the east coast of India; and provides logistics and other allied services inter alia rendering stevedoring, and other allied services in ports and other allied sectors. Further, the company is involved in manufacturing glass substrates in South Korea and Taiwan. It also has operations in South Africa, Namibia, Ireland, Australia, Liberia, and the United Arab Emirates. The company was incorporated in 1965 and is based in Mumbai, India.
Full VEDL Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.